May 26, 2023 — Atrial fibrillation, or AFib , is the most common heart rhythm problem, affecting millions of Americans ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
May 25, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and ...
May 24, 2023 — Stereotaxis announced a global collaboration with Abbott to integrate Abbott’s EnSite X EP System with ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 23, 2023 — The diagnosis of heart failure is usually missed, denying patients treatments that could improve ...
May 22, 2023 — Boston Scientific Corporation announced data supporting use of the company's key electrophysiology and ...
May 18, 2023 — Vektor Medical, pioneers of technology to accurately map arrhythmias using only 12-lead ECG data ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
May 17, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmiatreatment and part of Johnson & Johnson ...
The Heart Rhythm Society (HRS) announced the full lineup of speakers and sessions, including late-breaking clinical ...
The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
May 15, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
May 8, 2023 — An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves ...
April 25, 2023 — A score based on four readily available clinical and imaging parameters identifies the heart failure ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
April 20, 2023 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias ...
April 18, 2023 — Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting ...
April 18, 2023 — Medtronic today announced the 12-month findings that supported the Affera Mapping and Ablation System ...